Assessment of Muscle Function and Physical Performance in Daily Clinical Practice

Archive ouverte

Beaudart, Charlotte | Rolland, Yves | Cruz-Jentoft, Alfonso | Bauer, Jürgen | Sieber, Cornel | Cooper, Cyrus | Al-Daghri, Nasser | Araujo de Carvalho, Islene | Bautmans, Ivan | Bernabei, Roberto | Bruyère, Olivier | Cesari, Matteo | Cherubini, Antonio | Dawson-Hughes, Bess | Kanis, John | Kaufman, Jean-Marc | Landi, Francesco | Maggi, Stefania | Mccloskey, Eugene | Petermans, Jean | Rodriguez Mañas, Leocadio | Reginster, Jean-Yves | Roller-Wirnsberger, Regina | Schaap, Laura | Uebelhart, Daniel | Rizzoli, René | Fielding, Roger

Edité par CCSD ; Springer Verlag -

International audience. It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test-retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).

Consulter en ligne

Suggestions

Du même auteur

Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review

Archive ouverte | Bauer, Jürgen | CCSD

International audience. The co-existence of impaired bone health (osteopenia/osteoporosis), reduced muscle mass and strength (sarcopenia), and increased adiposity (obesity) in middle-aged and older people has been i...

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Archive ouverte | Beaudart, Charlotte | CCSD

International audience. Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures...

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group

Archive ouverte | Chevalley, Thierry | CCSD

International audience. Abstract Vitamin D is a key component for optimal growth and for calcium–phosphate homeostasis. Skin photosynthesis is the main source of vitamin D. Limited sun exposure and insufficient diet...

Chargement des enrichissements...